# Pancreatic Cancer Biomarker Study

> **NCT04143152** · — · UNKNOWN · sponsor: **Van Andel Research Institute** · enrollment: 300 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04143152
- **Lead sponsor:** Van Andel Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04143152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04143152, "Pancreatic Cancer Biomarker Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04143152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*